| Recruiting | New York Better Breathing Study NCT06869447 | Roswell Park Cancer Institute | N/A |
| Active Not Recruiting | Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients W NCT06732401 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer NCT06918132 | Mayo Clinic | Phase 2 |
| Recruiting | Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-S NCT06498635 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell NCT06632327 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Withdrawn | Oral Iloprost for the Prevention of Lung Cancer In Former Smokers NCT05411107 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung NCT05412875 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer NCT05292521 | Roswell Park Cancer Institute | N/A |
| Recruiting | Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Tre NCT05802186 | Northwestern University | N/A |
| Recruiting | A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer NCT06122064 | Mayo Clinic | N/A |
| Active Not Recruiting | Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer NCT05340309 | University of Southern California | Phase 2 |
| Recruiting | The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer NCT05502523 | Thomas Jefferson University | N/A |
| Recruiting | Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer NCT05136846 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence NCT04298606 | Roswell Park Cancer Institute | EARLY_Phase 1 |
| Recruiting | Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial NCT04789681 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer NCT04857697 | Mayo Clinic | EARLY_Phase 1 |
| Terminated | Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology T NCT04862195 | Blue Note Therapeutics | N/A |
| Terminated | Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients NCT04705025 | Jonsson Comprehensive Cancer Center | N/A |
| Recruiting | Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296 | M.D. Anderson Cancer Center | Phase 1 |
| Withdrawn | Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Pro NCT05022394 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-s NCT04751747 | Rutgers, The State University of New Jersey | N/A |
| Active Not Recruiting | NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer NCT04505267 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer NCT04348292 | Emory University | Phase 1 |
| Active Not Recruiting | Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients NCT04310020 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-sma NCT04214262 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer NCT04946279 | OHSU Knight Cancer Institute | N/A |
| Terminated | Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer NCT04560686 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Family Caregivers in Underserved Populations Providing Complex Cancer Care NCT05213078 | City of Hope Medical Center | N/A |
| Active Not Recruiting | Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer NCT04428905 | City of Hope Medical Center | Phase 3 |
| Recruiting | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small NCT04267848 | National Cancer Institute (NCI) | Phase 3 |
| Withdrawn | Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cel NCT04061590 | University of California, San Francisco | Phase 2 |
| Completed | Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plu NCT03801902 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes NCT04183218 | Mayo Clinic | — |
| Active Not Recruiting | Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small L NCT04013542 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study NCT04430725 | M.D. Anderson Cancer Center | — |
| Active Not Recruiting | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) NCT03811002 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer NCT03995667 | OHSU Knight Cancer Institute | Phase 2 |
| Active Not Recruiting | Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer NCT03939481 | SWOG Cancer Research Network | — |
| Recruiting | Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung NCT04067830 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or NCT03902535 | City of Hope Medical Center | — |
| Recruiting | Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non NCT03948100 | M.D. Anderson Cancer Center | N/A |
| Completed | Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients NCT03867916 | University of California, San Francisco | N/A |
| Active Not Recruiting | Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small NCT03731585 | M.D. Anderson Cancer Center | N/A |
| Completed | Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pu NCT03634241 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-sma NCT03132532 | Mayo Clinic | Phase 2 |